VM-PAIN-004
An oral repurposed therapeutic in late-stage development for complex regional pain syndrome.
An oral repurposed therapeutic in late-stage development for complex regional pain syndrome.
A novel small-molecule program being developed for severe neuropathic pain, including trigeminal neuralgia.
An investigational therapy aimed at improving pain control following surgical procedures.
An oral extended-release formulation being developed for individuals living with severe chronic pain.